Rupee snaps 2-day winning streak as dollar advances
Rupee snaps 2-day winning streak as dollar advances

Rupee snaps 2-day winning streak as dollar advances

Nidhi Jani Article rating: 5.0

The sentiments turned pessimistic as the Australia and New Zealand Banking Group (ANZ) slashed its forecast for India's economic growth to 6.2 per cent in the financial year ending March 2020 from a previous estimate of 6.5 per cent, warning it would be tough for authorities to engineer a turnaround.

IPO Update: Ujjivan Financial dips on filing for small bank IPO
IPO Update: Ujjivan Financial dips on filing for small bank IPO

IPO Update: Ujjivan Financial dips on filing for small bank IPO

Geyatee Deshpande Article rating: 3.4

Ujjivan Financial Services announced its decision to launch IPO of the company’s subsidiary Ujjivan Small Finance Bank (USFB). Reacting to this news, the stock of the company on Monday fell by nearly 8 per cent during intraday trade.

Sun Pharma gains on positive cues
Sun Pharma gains on positive cues

Sun Pharma gains on positive cues

Gayathri Udyawar Article rating: 3.5

Following a series of positive development, the stock of Sun Pharmaceutical was buzzing on Monday. The stock hit an intraday high of Rs. 434.20 per share, up more than 4 per cent.

Crompton features as Bollinger Band squeeze pick
Crompton features as Bollinger Band squeeze pick

Crompton features as Bollinger Band squeeze pick

Vinayak Gangule Article rating: 5.0

Crompton Greaves Consumer Electricals Limited was picked by our Bollinger Band squeeze scanner which suggests that the stock is near a consolidation breakout.

Glenmark gains on bagging approval for diabetes drug
Glenmark gains on bagging approval for diabetes drug

Glenmark gains on bagging approval for diabetes drug

Shohini Nath Article rating: 5.0

Shares of Glenmark Pharmaceuticals gained almost 3 per cent intraday after the company received regulatory approval to commercialise the combination drug under the brand names ‘Remo‐M’ and ‘Remozen‐M’.

Dr Reddy launches cancer drug in Indian market
Dr Reddy launches cancer drug in Indian market

Dr Reddy launches cancer drug in Indian market

Nidhi Jani Article rating: 5.0

Hyderabad-based pharma major Dr. Reddy's Laboratories has announced the launch of Versavo (bevacizumab biosimilar), 100 mg and 400 mg in the Indian Market on Monday. The said medicine is used for the treatment of several types of cancers.

RSS
First25662567256825692571257325742575Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR